Hepatocellular Adenoma: Cost-effectiveness of Different Treatment Strategies

References

• 1. Rooks JB , Ory HW , Ishak KG , et al.. Epidemiology of hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979; 242( 7): 644– 648.
  MedlineGoogle Scholar
• 2. Terkivatan T , de Wilt JH , de Man RA , van Rijn RR , Tilanus HW , IJzermans JN. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001; 88( 2): 207– 209.
  MedlineGoogle Scholar
• 3. van der Windt DJ , Kok NF , Hussain SM , et al.. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93( 12): 1495– 1502.
  MedlineGoogle Scholar
• 4. de Rave S , Hussain SM. A liver tumour as an incidental finding: differential diagnosis and treatment. Scand J Gastroenterol Suppl 2002; 236: 81– 86.
  MedlineGoogle Scholar
• 5. Hussain SM , van den Bos IC , Dwarkasing RS , Kuiper JW , den Hollander J. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol 2006; 16( 9): 1873– 1886.
  MedlineGoogle Scholar
• 6. Giusti S , Donati F , Paolicchi A , Bartolozzi C. Hepatocellular adenoma: imaging findings and pathological correlation. Dig Liver Dis 2005; 37( 3): 200– 205.
  MedlineGoogle Scholar
• 7. Chuang WY , Chen TC , Hsu HL , Lee WC , Jeng LB , Huang SF. Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases. J Formos Med Assoc 2002; 101( 11): 798– 802.
  MedlineGoogle Scholar
• 8. Ito M , Sasaki M , Wen CY , et al.. Liver cell adenoma with malignant transformation: a case report. World J Gastroenterol 2003; 9( 10): 2379– 2381.
  MedlineGoogle Scholar
• 9. Toso C , Majno P , Andres A , et al.. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol 2005; 11: 5691– 5695.
  MedlineGoogle Scholar
• 10. Cobey FC , Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187( 2): 181– 191.
  MedlineGoogle Scholar
• 11. Bis KA , Waxman B. Rupture of the liver associated with pregnancy: a review of the literature and report of 2 cases. Obstet Gynecol Surv 1976; 31( 11): 763– 773.
  MedlineGoogle Scholar
• 12. Choi BY , Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol 2005; 39( 5): 401– 412.
  MedlineGoogle Scholar
• 13. Biecker E , Fischer HP , Strunk H , Sauerbruch T. Benign hepatic tumours. Z Gastroenterol 2003; 41( 2): 191– 200.
  MedlineGoogle Scholar
• 14. Kammula US , Buell JF , Labow DM , Rosen S , Millis JM , Posner MC. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer 2001; 30( 3): 141– 146.
  MedlineGoogle Scholar
• 15. Ault GT , Wren SM , Ralls PW , Reynolds TB , Stain SC. Selective management of hepatic adenomas. Am Surg 1996; 62( 10): 825– 829.
  MedlineGoogle Scholar
• 16. Terkivatan T , de Wilt JH , de Man RA , et al.. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001; 136( 9): 1033– 1038.
  MedlineGoogle Scholar
• 17. Curley SA , Marra P , Beaty K , et al.. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004; 239( 4): 450– 458.
  MedlineGoogle Scholar
• 18. Briggs A , Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13( 4): 397– 409.
  MedlineGoogle Scholar
• 19. Sonnenberg FA , Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13( 4): 322– 338.
  MedlineGoogle Scholar
• 20. Beck JR , Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983; 3( 4): 419– 458.
  MedlineGoogle Scholar
• 21. Weinstein MC , Siegel JE , Gold MR , Kamlet MS , Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276( 15): 1253– 1258.
  MedlineGoogle Scholar
• 22. Statistics Netherlands Web site. http://www.cbs.nl. Accessed October 2007.
  Google Scholar
• 23. Briggs AH , Goeree R , Blackhouse G , O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 2002; 22( 4): 290– 308.
  MedlineGoogle Scholar
• 24. Erdogan D , Busch OR , van Delden OM , Ten Kate FJ , Gouma DJ , van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas: a single centre experience. Liver Int 2006; 26( 4): 433– 438.
  MedlineGoogle Scholar
• 25. Stoot JH , van der Linden E , Terpstra OT , Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg 2007; 94( 10): 1249– 1253.
  MedlineGoogle Scholar
• 26. Erdogan D , van Delden OM , Busch OR , Gouma DJ , van Gulik TM. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Intervent Radiol 2007; 30( 6): 1252– 1258.
  MedlineGoogle Scholar
• 27. Belghiti J , Hiramatsu K , Benoist S , Massault P , Sauvanet A , Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000; 191( 1): 38– 46.
  MedlineGoogle Scholar
• 28. Reddy KR , Kligerman S , Levi J , et al.. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001; 67( 2): 173– 178.
  MedlineGoogle Scholar
• 29. Ibrahim S , Chen CL , Wang SH , et al.. Liver resection for benign liver tumors: indications and outcome. Am J Surg 2007; 193( 1): 5– 9.
  MedlineGoogle Scholar
• 30. Chen MS , Li JQ , Zheng Y , et al.. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243( 3): 321– 328.
  MedlineGoogle Scholar
• 31. Choi D , Lim HK , Rhim H , et al.. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17( 3): 684– 692.
  MedlineGoogle Scholar
• 32. de Meijer VE , Verhoef C , Kuiper JW , Alwayn IP , Kazemier G , Ijzermans JN. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006; 10( 7): 960– 973.
  MedlineGoogle Scholar
• 33. Atwell TD , Brandhagen DJ , Charboneau JW , Nagorney DM , Callstrom MR , Farrell MA. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol 2005; 184( 3): 828– 831.
  MedlineGoogle Scholar
• 34. Cillo U , Vitale A , Brolese A , et al.. Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. J Surg Oncol 2007; 95( 3): 213– 220.
  MedlineGoogle Scholar
• 35. White TJ , Roy-Choudhury SH , Breen DJ , et al.. Percutaneous radiofrequency ablation of colorectal hepatic metastases: initial experience—an adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 2004; 21( 4): 314– 320.
  MedlineGoogle Scholar
• 36. Wong JB , Bennett WG , Koff RS , Pauker SG. Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. JAMA 1998; 280( 24): 2088– 2093.
  MedlineGoogle Scholar
• 37. Wells CD , Murrill WB , Arguedas MR. Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease. Dig Dis Sci 2004; 49( 3): 453– 458.
  MedlineGoogle Scholar
• 38. Martin RC , Eid S , Scoggins CR , McMasters KM. Health-related quality of life: return to baseline after major and minor liver resection. Surgery 2007; 142( 5): 676– 684.
  MedlineGoogle Scholar
• 39. Oostenbrink JB , Koopmanschap MA , Rutten FF. Standardisation of costs: the Dutch Manual for Costing in Economic Evaluations. Pharmacoeconomics 2002; 20( 7): 443– 454.
  MedlineGoogle Scholar
• 40. Brown RE , De Cock E , Colin X , Antoñanzas F , Iloeje UH. Hepatitis B management costs in France, Italy, Spain, and the United Kingdom. J Clin Gastroenterol 2004; 38( 10 suppl 3): S169– S174.
  MedlineGoogle Scholar
• 41. Edmondson HA , Henderson B , Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976; 294( 9): 470– 472.
  MedlineGoogle Scholar
• 42. Baum JK , Bookstein JJ , Holtz F , Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2( 7835): 926– 929.
  MedlineGoogle Scholar
• 43. Fryback DG , Dasbach EJ , Klein R , et al.. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13( 2): 89– 102.
  MedlineGoogle Scholar
• 44. FXHistory: historical currency exchange rates. OANDA Web site. http://www.oanda.com/convert/fxhistory. Accessed January 2008.
  Google Scholar
• 45. Stinnett AA , Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998; 18( 2 suppl): S68– S80.
  MedlineGoogle Scholar
• 46. Claxton K , Sculpher M , Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002; 360( 9334): 711– 715.
  MedlineGoogle Scholar
• 47. Groot Koerkamp B , Nikken JJ , Oei EH , Stijnen T , Ginai AZ , Hunink MG. Value of information analysis used to determine the necessity of additional research: MR imaging in acute knee trauma as an example. Radiology 2008; 246( 2): 420– 425.
  Google Scholar
• 48. Groot Koerkamp B , Myriam Hunink MG , Stijnen T , Weinstein MC. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods. Health Econ 2006; 15( 4): 383– 392.
  MedlineGoogle Scholar
• 49. Yokota F , Thompson KM. Value of information literature analysis: a review of applications in health risk management. Med Decis Making 2004; 24( 3): 287– 298.
  MedlineGoogle Scholar
• 50. Fortner JG , Blumgart LH. A historic perspective of liver surgery for tumors at the end of the millennium. J Am Coll Surg 2001; 193( 2): 210– 222.
  MedlineGoogle Scholar
• 51. Rocourt DV , Shiels WE , Hammond S , Besner GE. Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg 2006; 41( 6): 1149– 1152.
  MedlineGoogle Scholar
• 52. Rhim H , Lim HK , Kim YS , Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol 2008; 23( 8 pt 2): e422– e427.
  MedlineGoogle Scholar